BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, July 14, 2026
Home » Authors » Brady Huggett

Articles by Brady Huggett

GenStar, Vascular Genetics To Form Autus, Combine Focuses

Sep. 16, 2002
By Brady Huggett
Vascular Genetics Inc. and GenStar Therapeutics Corp. are merging to form Autus Genetics Corp., a company that will focus on the lead products of both of its parts. The merger was born out of a conversation between the two heads of the companies early this year. (BioWorld Today)
Read More

GenStar, Vascular Genetics To Form Autus, Combine Focuses

Sep. 16, 2002
By Brady Huggett
Vascular Genetics Inc. and GenStar Therapeutics Corp. are merging to form Autus Genetics Corp., a company that will focus on the lead products of both of its parts. The merger was born out of a conversation between the two heads of the companies early this year. (BioWorld Today)
Read More

IDEC Views Early IDEC-114 Data In Psoriasis, Drops Indication

Sep. 6, 2002
By Brady Huggett

IDEC Views Early IDEC-114 Data In Psoriasis, Drops Indication

Sep. 6, 2002
By Brady Huggett

Aventis Declines Option For Alliance On Indevus' Pagoclone

Sep. 3, 2002
By Brady Huggett

Aventis Declines Option For Alliance On Indevus' Pagoclone

Sep. 3, 2002
By Brady Huggett

Alliance Cuts Staff, Pressures Venture For Oxygent Funding

Aug. 30, 2002
By Brady Huggett
Alliance Pharmaceutical Corp. has spent more than $200 million developing its intravascular oxygen carrier, Oxygent. But now facing a revised development plan that it cannot afford, Alliance cut 40 percent of its work force and warned PFC Therapeutics LLC, the joint venture set up to commercialize the product, that if funds don't materialize, the Oxygent license agreement will be terminated and the joint venture dissolved. (Bioworld Today)
Read More

Alliance Cuts Staff, Pressures Venture For Oxygent Funding

Aug. 30, 2002
By Brady Huggett
Alliance Pharmaceutical Corp. has spent more than $200 million developing its intravascular oxygen carrier, Oxygent. But now facing a revised development plan that it cannot afford, Alliance cut 40 percent of its work force and warned PFC Therapeutics LLC, the joint venture set up to commercialize the product, that if funds don't materialize, the Oxygent license agreement will be terminated and the joint venture dissolved. (Bioworld Today)
Read More

FDA-Requested Report Examines Animal Biotechnology Concerns

Aug. 26, 2002
By Brady Huggett
In a report that was requested by the FDA to better arm itself for the upcoming animal biotechnology regulatory decisions it will surely face, the National Academies' National Research Council said the gravest concern associated with the merging of biotechnology and animals is environmental. (BioWorld Today)
Read More

FDA-Requested Report Examines Animal Biotechnology Concerns

Aug. 26, 2002
By Brady Huggett
In a report that was requested by the FDA to better arm itself for the upcoming animal biotechnology regulatory decisions it will surely face, the National Academies' National Research Council said the gravest concern associated with the merging of biotechnology and animals is environmental. (BioWorld Today)
Read More
Previous 1 2 … 52 53 54 55 56 57 58 59 60 … 74 75 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 13, 2026.
  • AI-generated  illustration of a neuron with tau protein aggregation

    AAIC 2026: Age of amyloid is being joined by time of tau

    BioWorld
    The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
  • Modius Spero wearable neuromodulation device

    Neurovalens granted FDA approval for PTSD therapy for US veterans

    BioWorld
    Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
  • NRF2 activators reported in Vailima Peninsula patent

    BioWorld Science
    Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 14, 2026
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing